XBIOTECH INC. Increase (Decrease) in Accrued Liabilities
XBIOTECH INC. (XBIT) reported Increase (Decrease) in Accrued Liabilities of -$4.07 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedLiabilities · last filed 2026-08-13
- XBIOTECH INC. increase (decrease) in accrued liabilities for the quarter ending 2026-06-30 was $212.00K.
- XBIOTECH INC. increase (decrease) in accrued liabilities for the quarter ending 2026-03-31 was -$4.28M, a 356.31% decline year-over-year.
- XBIOTECH INC. increase (decrease) in accrued liabilities for the quarter ending 2025-12-31 was $3.90M.
- XBIOTECH INC. increase (decrease) in accrued liabilities for the quarter ending 2025-09-30 was $12.00K.
- XBIOTECH INC. increase (decrease) in accrued liabilities for fiscal 2025 was $3.69M.
- XBIOTECH INC. increase (decrease) in accrued liabilities for fiscal 2024 was -$877.00K, a 146.28% decline from fiscal 2023.
- XBIOTECH INC. increase (decrease) in accrued liabilities for fiscal 2023 was $1.90M, a 727.51% increase from fiscal 2022.
- XBIOTECH INC. increase (decrease) in accrued liabilities for fiscal 2022 was $229.00K, a 895.65% increase from fiscal 2021.
| Period end | Increase (Decrease) in Accrued Liabilities 3 month | Increase (Decrease) in Accrued Liabilities 6 month | Increase (Decrease) in Accrued Liabilities 9 month | Increase (Decrease) in Accrued Liabilities 12 month |
|---|---|---|---|---|
| 2026-06-30 | $212.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | -$4.07M 10-Q · filed 2026-08-13 | -$175.00K derived: sum of 3 quarters · filed 2026-08-13 | -$163.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | -$4.28M 10-Q · filed 2026-05-14 | -$387.00K derived: sum of 2 quarters · filed 2026-05-14 | -$375.00K derived: sum of 3 quarters · filed 2026-05-14 | -$2.27M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | $3.90M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-13 | $3.91M derived: sum of 2 quarters · filed 2026-03-13 | $2.02M derived: sum of 3 quarters · filed 2026-08-13 | $3.69M 10-K · filed 2026-03-13 |
| 2025-09-30 | $12.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$1.88M derived: sum of 2 quarters · filed 2026-08-13 | -$210.00K 10-Q · filed 2025-11-12 | -$2.07M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | -$1.89M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | -$222.00K 10-Q · filed 2026-08-13 | -$2.08M derived: sum of 3 quarters · filed 2026-08-13 | -$2.95M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | $1.67M 10-Q · filed 2026-05-14 | -$192.00K derived: sum of 2 quarters · filed 2026-05-14 | -$1.05M derived: sum of 3 quarters · filed 2026-05-14 | $100.00K derived: sum of 4 quarters · filed 2026-05-14 |
| 2024-12-31 | -$1.86M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-13 | -$2.72M derived: sum of 2 quarters · filed 2026-03-13 | -$1.57M derived: sum of 3 quarters · filed 2026-03-13 | -$877.00K 10-K · filed 2026-03-13 |
| 2024-09-30 | -$861.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $292.00K derived: sum of 2 quarters · filed 2025-11-12 | $986.00K 10-Q · filed 2025-11-12 | $818.00K derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | $1.15M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | $1.85M 10-Q · filed 2025-08-13 | $1.68M derived: sum of 3 quarters · filed 2025-08-13 | $2.71M derived: sum of 4 quarters · filed 2025-08-13 |
| 2024-03-31 | $694.00K 10-Q · filed 2025-05-14 | $526.00K derived: sum of 2 quarters · filed 2025-05-14 | $1.56M derived: sum of 3 quarters · filed 2025-05-14 | $1.99M derived: sum of 4 quarters · filed 2025-05-14 |
| 2023-12-31 | -$168.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-18 | $864.00K derived: sum of 2 quarters · filed 2025-03-18 | $1.29M derived: sum of 3 quarters · filed 2025-03-18 | $1.90M 10-K · filed 2025-03-18 |
| 2023-09-30 | $1.03M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | $1.46M derived: sum of 2 quarters · filed 2024-11-13 | $2.06M 10-Q · filed 2024-11-13 | $1.68M derived: sum of 4 quarters · filed 2024-11-13 |
| 2023-06-30 | $429.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-12 | $1.03M 10-Q · filed 2024-08-12 | $646.00K derived: sum of 3 quarters · filed 2024-08-12 | -$2.96M derived: sum of 4 quarters · filed 2024-08-12 |
| 2023-03-31 | $602.00K 10-Q · filed 2024-05-10 | $217.00K derived: sum of 2 quarters · filed 2024-05-10 | -$3.38M derived: sum of 3 quarters · filed 2024-05-10 | $637.00K derived: sum of 4 quarters · filed 2024-05-10 |
| 2022-12-31 | -$385.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-15 | -$3.99M derived: sum of 2 quarters · filed 2024-03-15 | $35.00K derived: sum of 3 quarters · filed 2024-03-15 | $229.00K 10-K · filed 2024-03-15 |
| 2022-09-30 | -$3.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $420.00K derived: sum of 2 quarters · filed 2023-11-09 | $614.00K 10-Q · filed 2023-11-09 | $345.00K derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | $4.02M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-11 | $4.21M 10-Q · filed 2023-08-11 | $3.95M derived: sum of 3 quarters · filed 2023-08-11 | $3.91M derived: sum of 4 quarters · filed 2023-08-11 |
| 2022-03-31 | $194.00K 10-Q · filed 2023-05-10 | -$75.00K derived: sum of 2 quarters · filed 2023-05-10 | -$113.00K derived: sum of 3 quarters · filed 2023-05-10 | $227.00K derived: sum of 4 quarters · filed 2023-05-10 |
| 2021-12-31 | -$269.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-15 | -$307.00K derived: sum of 2 quarters · filed 2023-03-15 | $33.00K derived: sum of 3 quarters · filed 2023-03-15 | $23.00K 10-K · filed 2023-03-15 |
| 2021-09-30 | -$38.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $302.00K derived: sum of 2 quarters · filed 2022-11-09 | $292.00K 10-Q · filed 2022-11-09 | -$663.00K derived: sum of 4 quarters · filed 2022-11-09 |
| 2021-06-30 | $340.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-10 | $330.00K 10-Q · filed 2022-08-10 | -$625.00K derived: sum of 3 quarters · filed 2022-08-10 | -$3.15M derived: sum of 4 quarters · filed 2022-08-10 |
| 2021-03-31 | -$10.00K 10-Q · filed 2022-05-10 | -$965.00K derived: sum of 2 quarters · filed 2022-05-10 | -$3.49M derived: sum of 3 quarters · filed 2022-05-10 | -$24.00K derived: sum of 4 quarters · filed 2022-05-10 |
| 2020-12-31 | -$955.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-15 | -$3.48M derived: sum of 2 quarters · filed 2022-03-15 | -$14.00K derived: sum of 3 quarters · filed 2022-03-15 | -$2.83M 10-K · filed 2022-03-15 |
| 2020-09-30 | -$2.52M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $941.00K derived: sum of 2 quarters · filed 2021-11-09 | -$1.87M 10-Q · filed 2021-11-09 | $1.34M derived: sum of 4 quarters · filed 2022-03-15 |
| 2020-06-30 | $3.47M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | $651.00K 10-Q · filed 2021-08-09 | $3.87M derived: sum of 3 quarters · filed 2022-03-15 | $3.92M derived: sum of 4 quarters · filed 2022-03-15 |
| 2020-03-31 | -$2.81M 10-Q · filed 2021-05-10 | $404.00K derived: sum of 2 quarters · filed 2022-03-15 | $452.00K derived: sum of 3 quarters · filed 2022-03-15 | $384.00K derived: sum of 4 quarters · filed 2022-03-15 |
| 2019-12-31 | $3.22M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-15 | $3.27M derived: sum of 2 quarters · filed 2022-03-15 | $3.20M derived: sum of 3 quarters · filed 2022-03-15 | $2.89M 10-K · filed 2022-03-15 |
| 2019-09-30 | $48.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | -$20.00K derived: sum of 2 quarters · filed 2020-11-09 | -$331.00K 10-Q · filed 2020-11-09 | -$462.00K derived: sum of 4 quarters · filed 2021-03-16 |
| 2019-06-30 | -$68.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | -$379.00K 10-Q · filed 2020-08-10 | -$510.00K derived: sum of 3 quarters · filed 2021-03-16 | -$390.00K derived: sum of 4 quarters · filed 2021-03-16 |
| 2019-03-31 | -$311.00K 10-Q · filed 2020-05-11 | -$442.00K derived: sum of 2 quarters · filed 2021-03-16 | -$322.00K derived: sum of 3 quarters · filed 2021-03-16 | -$294.00K derived: sum of 4 quarters · filed 2021-03-16 |
| 2018-12-31 | -$131.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-16 | -$11.00K derived: sum of 2 quarters · filed 2021-03-16 | $17.00K derived: sum of 3 quarters · filed 2021-03-16 | $229.00K 10-K · filed 2021-03-16 |
| 2018-09-30 | $120.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $148.00K derived: sum of 2 quarters · filed 2019-11-12 | $360.00K 10-Q · filed 2019-11-12 | |
| 2018-06-30 | $28.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | $240.00K 10-Q · filed 2019-08-09 | ||
| 2018-03-31 | $212.00K 10-Q · filed 2019-05-09 | |||
| 2017-12-31 | -$2.47M 10-K · filed 2020-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |